At a glance
ClinicalIndex Comparison Record- ✓Married women
- ✓First pregnancy during the trial period
- ✕Previous pregnancy history during trial enrollment
- ✕Premenarchial girls
- ✕Previously married women who have moved into study area
- ✕Single women (never married, widowers)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh
In Brief
A Phase 3 clinical trial evaluating Vitamin A or Beta-Carotene Supplements for Vitamin A Deficiency and 2 related conditions. Completed, enrolled 59,666 participants across 3 sites in 2 countries.
Detailed Summary
The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.
Study Details
Timeline
Interventions
weekly dosage of either 7000 µg retinol equivalents as preformed vitamin A or 42 mg of beta-carotene from 1st trimester of pregnancy through 12 weeks after termination of pregnancy